Comparison Of The Effects Of Intravenous Metoclopramide And Ondansetron On Prevention Of Nausea And Vomiting After Cesarean Section

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170502033762N2

Enrollment

120

Registered

2018-02-22

Start date

2016-05-04

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting. Nausea with vomiting, unspecified

Interventions

Intervention 1: Intervention group: Ondansetron (produced by Abidi Company) 4 mg in 10 cc normal saline was Infused before surgery. Intervention 2: Control group (routine treatment): Methoclopramide (

Eligibility

Sex/Gender

Female

Age

15 Years to 50 Years

Inclusion criteria

Inclusion criteria: Pregnant women who were undergoing elective cesarean section at the Amir-Almomenin hospital in Zabol Women aged 18-40 years

Exclusion criteria

Exclusion criteria: History Of severe Nausea and Vomiting History Of Severe Dizziness In The Car (motion sickness) History Of Drug Use No Anti-Nausea Medicine use high blood pressure in pregnancy

Design outcomes

Secondary

Measure	Time frame
Nausea and vomiting. Timepoint: Every six hours. Method of measurement: Direct observation by technician and asking from the patient.	—

Primary

Measure	Time frame
Nausea And Vomiting. Timepoint: Immediately after the intervention, six hours after the intervention, 12 hours after the intervention, 18 hours after the intervention and 24 hours after the intervention. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Mosaed

Zabol University of Medical Sciences

mosaedsaeed1372@gmail.com+98 54 3762 7732

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026